The Evolving Landscape of Systemic Therapy for Liposarcoma
Cancers · 22.05.2026 · 18 (11) · 1694
DOI: 10.3390/cancers18111694 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 22.05.2026. Verfasst von Hee Kyung Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Chao Family Comprehensive Cancer Center, University of California, Orange, CA 92868, USA. Die Arbeit nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Liposarcoma represents a heterogeneous group of mesenchymal malignancies with distinct molecular profiles and clinical behaviors. While localized disease is managed with surgical resection, advanced or metastatic liposarcoma poses a significant therapeutic challenge due to limited response to traditional cytotoxic chemotherapy. This review summarizes current evidence-based systemic therapies and highlights recent advances in subtype-driven treatment strategies.
Methods
We review key clinical trials supporting the use of anthracycline regimens, trabectedin, eribulin, and nuclear export inhibition with selinexor, as well as emerging targeted approaches directed at MDM2 and CDK4 amplification. In addition, we discuss the evolving role of immunotherapy, including checkpoint inhibitors and engineered T-cell receptor therapies targeting cancer–testis antigens.
Results
Integrating molecular biology with therapeutic development, we emphasize the importance of histologic and genomic classification in guiding treatment selection and clinical trial design.
Conclusion
Continued progress in biomarker-driven strategies and rational combination therapies is expected to further refine personalized treatment approaches and improve outcomes for patients with advanced liposarcoma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chao Family Comprehensive Cancer Center, University of California, Orange, CA 92868, USA.
- Division of Hematology/Oncology, Department of Medicine, University of California, Orange, CA 92868, USA.
- Department of Internal Medicine, Chungbuk National University Hospital, Cheongju 28644, Republic of Korea.
ORCID-Profile: Warren A Chow
Zitieren
APA
Kim, H. K., Sarkari, A., & Chow, W. A. (2026). The Evolving Landscape of Systemic Therapy for Liposarcoma. Cancers, 18(11), 1694. https://doi.org/10.3390/cancers18111694
Vancouver
Kim HK, Sarkari A, Chow WA. The Evolving Landscape of Systemic Therapy for Liposarcoma. Cancers. 2026;18(11):1694. doi:10.3390/cancers18111694
BibTeX
@article{Kim2026,
author = {Kim, Hee Kyung and Sarkari, Akshat and Chow, Warren A},
title = {The Evolving Landscape of Systemic Therapy for Liposarcoma},
journal = {Cancers},
year = {2026},
volume = {18},
number = {11},
pages = {1694},
doi = {10.3390/cancers18111694}
}
EUVIMED